BioXcel Therapeutics, Inc.

8-K Entered a material agreement Aug 3, 2026 8-K Entered a material agreement Jul 6, 2026 8-K Results of operations (earnings release) May 15, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Unregistered sale of equity Apr 17, 2026 8-K Other events Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release) Mar 27, 2026 8-K Entered a material agreement Mar 11, 2026 8-K Other events Feb 12, 2026 8-K Director or officer change Feb 6, 2026 8-K Other events Jan 20, 2026 8-K Other events Jan 12, 2026 8-K Shareholder vote results Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Other events Nov 10, 2025 8-K Other events Oct 30, 2025 8-K Other events Oct 14, 2025 8-K Regulation FD disclosure; Other events Sep 15, 2025 8-K Other events Sep 10, 2025 8-K Other events Aug 27, 2025 8-K Other events Aug 18, 2025 8-K Other events Aug 18, 2025 8-K Other events Aug 15, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Regulation FD disclosure Aug 11, 2025 8-K Other events Aug 11, 2025 8-K Other events Aug 6, 2025 8-K Other events Aug 1, 2025 8-K Other events Jul 21, 2025 8-K Other events Jul 15, 2025 8-K Other events May 27, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Entered a material agreement Apr 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Delisting notice or listing-rule failure Mar 21, 2025